Tenaya Therapeutics Inc (NASDAQ:TNYA) price on Thursday, March 20, fall -6.12% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.66.
A look at the stock’s price movement, the close in the last trading session was $0.70, moving within a range at $0.65 and $0.698. The beta value (5-Year monthly) was 2.841. Turning to its 52-week performance, $5.32 and $0.39 were the 52-week high and 52-week low respectively. Overall, TNYA moved -41.51% over the past month.
Tenaya Therapeutics Inc’s market cap currently stands at around $106.51 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-09.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TNYA is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend TNYA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TNYA’s current price about -11.40% and -34.75% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.32, while 7-day volatility ratio is 9.79% and 14.58% in the 30-day chart. Further, Tenaya Therapeutics Inc (TNYA) has a beta value of 2.91, and an average true range (ATR) of 0.10.
If we refocus on Tenaya Therapeutics Inc (NASDAQ:TNYA), historical trading data shows that trading volumes averaged 6.57 over the past 10 days and 3.62 million over the past 3 months. The company’s latest data on shares outstanding shows there are 162.58 million shares.
The 17.52% of Tenaya Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 20.24% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 14.4 million on 2025-02-28, giving us a short ratio of 8.63. The data shows that as of 2025-02-28 short interest in Tenaya Therapeutics Inc (TNYA) stood at 2602.0 of shares outstanding, with shares short rising to 12.24 million registered in 2025-01-31. Current price change has pushed the stock -54.19% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TNYA stock continues to rise going into the next quarter.
